Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Pharmaceutical Distributors are at the Forefront of Cold Chain Logistics
As the fight against the coronavirus pandemic continues, the successful development of effective COVID-19 vaccines will represent a pivotal moment in our country’s efforts to end this public health crisis. However, the discovery of a vaccine is just the first step of many to ensure these critical medicines are widely accessible to providers and their patients.
Rx Sales Through HDA Healthcare Distributors Remained Strong in 2021, Accounting for 94 Percent of Overall Market
According to the HDA Research Foundation, approximately 94 percent of pharmaceutical sales were completed through healthcare distributors in 2021. As reported in the 93rd Edition HDA Factbook, sales through traditional healthcare distributors rose by a record-high 9.4 percent to reach $598.7 billion as the COVID-19 pandemic entered its second year.
Morris & Dickson’s Jody Hatcher and Cardinal Health’s Debbie Weitzman To Lead HDA Board of Directors
The Healthcare Distribution Alliance (HDA) announced Jody Hatcher, CEO of Morris & Dickson Co., L.L.C., as the Chair of its Board of Directors at the association's Annual Board and Membership Meeting. Debbie Weitzman, CEO of Pharmaceutical and Specialty Solutions, Cardinal Health, Inc., is Vice Chair.
HDA Factbook: Rx Sales Through Traditional Healthcare Distributors Increase
New data released by the HDA Research Foundation reveal that total prescription sales through traditional pharmaceutical distribution jumped 15.5 percent in 2022 to reach $666 billion. As highlighted in the 94th Edition HDA Factbook, an estimated 95 percent of all pharmaceutical sales move through the traditional distribution channel. Moreover, distributors are operating on the lowest margins in the study’s history — in 2022, the industry’s net profit margin after taxes was 0.4 percent.